{"url":"https://etfiq.com/compare/leverage/cure-vs-rxl","section":"compare","title":"CURE vs RXL: which held to its multiple? | ETFIQ","description":"CURE sets out to return +3 times XLV each day and RXL +2 times. Over the three months to Sep 30, 2026 they finished \u22124.1 pts and \u22121.2 pts away.","as_of":"Sep 30, 2026","structured_data":[{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Which came closer to its stated multiple, CURE or RXL?","acceptedAnswer":{"@type":"Answer","text":"Over the window to Sep 30, 2026, CURE finished 4.1 points from what its multiple implies and RXL finished 1.2 points from its own, so RXL came closer. Neither figure predicts the next window: it depends on how much the underlying moves about."}},{"@type":"Question","name":"Are CURE and RXL levered on the same thing?","acceptedAnswer":{"@type":"Answer","text":"Yes. Both are levered on health care, CURE at +3 times and RXL at +2 times the daily move."}},{"@type":"Question","name":"Which one decays faster, CURE or RXL?","acceptedAnswer":{"@type":"Answer","text":"Decay follows how much the underlying moves about. Over this window CURE\u2019s moved at 18% annualized and RXL\u2019s at 18%, so CURE has the rougher ride and, at the same multiple, loses more to compounding."}},{"@type":"Question","name":"Can I hold CURE or RXL for a year?","acceptedAnswer":{"@type":"Answer","text":"Both reset every day, so the multiple in the name applies to a single day and the daily results compound. Over a year the total is not the multiple times the year\u2019s move, and in a market that falls and comes back it is reliably less. ETFIQ makes no recommendation either way."}},{"@type":"Question","name":"Which is cheaper, CURE or RXL?","acceptedAnswer":{"@type":"Answer","text":"CURE charges 0.94% a year and RXL charges 0.95%, so CURE is cheaper. Fees come from each fund's prospectus."}}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"ETFIQ","item":"https://etfiq.com/"},{"@type":"ListItem","position":2,"name":"Leveraged ETFs","item":"https://etfiq.com/leverage/"},{"@type":"ListItem","position":3,"name":"CURE vs RXL","item":"https://etfiq.com/compare/leverage/cure-vs-rxl"}]},{"@type":"WebPage","name":"CURE vs RXL: which held to its multiple?","description":"CURE sets out to return +3 times XLV each day and RXL +2 times. Over the three months to Sep 30, 2026 they finished \u22124.1 pts and \u22121.2 pts away.","url":"https://etfiq.com/compare/leverage/cure-vs-rxl","dateModified":"2026-09-30","abstract":"Over three months against its own daily promise, CURE finished 2.5 points short and RXL 0.7 points short.","publisher":{"@id":"https://etfiq.com/#org"},"isPartOf":{"@id":"https://etfiq.com/#website"},"speakable":{"@type":"SpeakableSpecification","cssSelector":[".verdict",".faq"]}},{"@type":"Dataset","name":"ETFIQ comparison of CURE and RXL","description":"CURE sets out to return +3 times XLV each day and RXL +2 times. Over the three months to Sep 30, 2026 they finished \u22124.1 pts and \u22121.2 pts away.","dateModified":"2026-09-30","creator":{"@id":"https://etfiq.com/#org"},"isAccessibleForFree":true,"url":"https://etfiq.com/compare/leverage/cure-vs-rxl","license":"https://etfiq.com/standards/","publisher":{"@id":"https://etfiq.com/#org"},"inLanguage":"en","creativeWorkStatus":"Published","distribution":[{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/leverage.json"}],"variableMeasured":["Stated multiple","Underlying return","What the stated multiple implies","Fund total return","Difference against the label","Volatility of the underlying","Expense ratio"],"keywords":["exchange-traded funds","ETF","Leveraged ETFs","fund data","SEC filings"]}],"characters":6834,"truncated":true,"content":"ETFIQ / Leveraged ETFs / Head to head / CURE vs RXL \n ETFIQ etfiq.com \u00b7 independent ETF data \n\n Data as of Sep 30, 2026 .\n\n CURE vs RXL: which held to its multiple?\n\n Over three months against its own daily promise, CURE finished 2.5 points short and RXL 0.7 points short.\n Copy this for sharing \n \n Direxion Daily Healthcare Bull 3X ETF and ProShares Ultra Health Care.\n\n Download as PDF \n\n +13.8% CURE returned, 3 months \n +10.7% RXL returned, 3 months \n \u22124.1 pts CURE from its stated multiple \n \u22121.2 pts RXL from its stated multiple \n\n ETFIQ Decay Resistance Score: RXL scores higher\n Did it keep ","source":"ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.","publisher":{"@id":"https://etfiq.com/#org","name":"ETFIQ","url":"https://etfiq.com"},"license":"https://etfiq.com/license/","citation":"ETFIQ, as of Sep 30, 2026. https://etfiq.com/compare/leverage/cure-vs-rxl","a":{"ticker":"CURE","name":"Direxion Daily Healthcare Bull 3X ETF","issuer":"Direxion","desk":"leverage","as_of":"2026-09-30","verdict":"Three months to Sep 30, 2026: CURE returned +13.8% where its own daily promise gave +16.3%, 2.5 points short.","url":"https://etfiq.com/funds/cure","key_facts":[{"label":"What XLV did","value":"+6.0%","as_of":"2026-09-30","source":null},{"label":"What 3 times a day gives","value":"+16.3%","as_of":"2026-09-30","source":null},{"label":"What the fund returned","value":"+13.8%","as_of":"2026-09-30","source":null},{"label":"The fund itself cost","value":"\u22122.5 pts","as_of":"2026-09-30","source":null},{"label":"Net assets","value":"$168m","as_of":"2026-09-30","source":"issuer page, as of Sep 30, 2026"},{"label":"Expense ratio","value":"0.94%","as_of":"2026-09-30","source":"485BPOS XBRL, Feb 26, 2026"}]},"b":{"ticker":"RXL","name":"ProShares Ultra Health Care","issuer":"ProShares","desk":"leverage","as_of":"2026-09-30","verdict":"Three months to Sep 30, 2026: RXL returned +10.7% where its own daily promise gave +11.4%, 0.7 points short.","url":"https://etfiq.com/funds/rxl","key_facts":[{"label":"What XLV did","value":"+6.0%","as_of":"2026-09-30","source":null},{"label":"What 2 times a day gives","value":"+11.4%","as_of":"2026-09-30","source":null},{"label":"What the fund returned","value":"+10.7%","as_of":"2026-09-30","source":null},{"label":"The fund itself cost","value":"\u22120.7 pts","as_of":"2026-09-30","source":null},{"label":"Net assets","value":"$97m","as_of":"2026-09-30","source":"issuer page, as of Sep 30, 2026"},{"label":"Expense ratio","value":"0.95%","as_of":"2026-09-30","source":"485BPOS XBRL, Sep 25, 2026"}]},"overlap_pct":null,"overlap_note":"ETFIQ does not publish a holdings overlap for this pair. Either the funds are not compared on holdings, or one book is incomplete.","full_text_at":"https://etfiq.com/compare/leverage/cure-vs-rxl"}